Locally available heparin modulates inflammatory cell recruitment in a manner independent of anticoagulant activity

European Journal of Pharmacology

Volumn 630, Issue 1-3, 2010, Pages 137-144

  Lever, Rebecca ^a   Smailbegovic, Amir ^a,b   Page, Clive P ^b  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Adhesion; Endothelium; Heparin; Inflammation; Neutrophil

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HEPARIN; HEPARIN DERIVATIVE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 8; LOW MOLECULAR WEIGHT HEPARIN; N DESULFOHEPARIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE ADHERENCE; LEUKOCYTE AGGREGATION; LEUKOCYTE MIGRATION; LEUKOCYTE ROLLING; MALE; MESENTERY BLOOD FLOW; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PERITONITIS; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTICOAGULANTS; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPARIN; MALE; NEUTROPHILS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77649181493     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.12.015     Document Type: Article

References (47)

1. Ahmed T., Garrigo J., Danta I. Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin. N. Engl. J. Med. 1993, 329:90-95.
2. Ahmed T., Gonzalez B.J., Danta I. Prevention of exercise-induced bronchoconstriction by inhaled low-molecular-weight heparin. Am. J. Respir. Crit. Care Med. 1999, 160:576-581.
3. Bârzu T., Van Rijn J.L.M.L., Petitou M., Molho P., Tobelem G., Jacques P.C. Endothelial binding sites for heparin. Specificity and role in heparin neutralization. Biochem. J. 1986, 238:847-854.
4. Bazzoni G., Nuñez A.B., Mascellani G., Bianchini P., Dejana E., Del Maschio A. Effect of heparin, dermatan sulfate, and related oligo-derivatives on human polymorphonuclear leukocyte functions. J. Lab. Clin. Med. 1992, 121:268-275.
5. Bendstrup K.E., Gram J., Jensen J.I. Effect of inhaled heparin on lung function and coagulation in healthy volunteers. Eur. Respir. J. 2002, 19:606-610.
6. Brown R.A., Lever R., Jones N.A., Page C.P. Effects of heparin and related molecules upon neutrophil aggregation and elastase release in vitro. Br. J. Pharmacol. 2003, 139:845-853.
7. Cripps J.G., Crespo F.A., Romanovskis P., Spatola A.F., Fernandez-Botran R. Modulation of acute inflammation by targeting glycosaminoglycan-cytokine interactions. Int. Immunopharmacol. 2005, 5:1622-1632.
8. Diamond M.S., Staunton D.E., Marlin S.D., Springer T.A. Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell 1991, 65:961-971.
9. Ertas N.M., Goldman C., Deitcher S., Siemionow M. Dose response of enoxaparin at the cremaster muscle flap microcirculation. Microsurgery 2005, 25:147-151.
10. Forsberg E., Pejler G., Ringvall M., Lunderius C., Tomasini-Johansson B., Kusche-Gullberg M., Eriksson I., Ledin J., Hellman L., Kjellen L. Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme. Nature 1999, 400:773-776.
11. Fritzsche J., Alban S., Ludwig R.J., Rubant S., Boehncke W.-H., Schumacher G., Bendas G. The influence of various structural parameters of semisynthetic sulphated polysaccharides on the P-selectin inhibitory capacity. Biochem. Pharmacol. 2006, 72:474-485.
12. Fryer A., Huang Y.C., Rao G., Jacoby D., Mancilla E., Whorton R., Piantadosi C.A., Kennedy T., Hoidal J. Selective O-desulfation produces nonanticoagulant heparin that retains pharmacological activity in the lung. J. Pharmacol. Exp. Ther. 1997, 282:208-219.
13. Goncalves de Moraes V.L., Vargaftig B., Lefort J., Meager A., Chignard M. Effect of cyclo-oxygenase inhibitors and modulators of cyclic AMP formation on lipopolysaccharide-induced neutrophil infiltration in mouse lung. Br. J. Pharmacol. 1996, 117:1792-1796.
14. Green W.F., Konnaris K., Woolcock A.J. Effect of salbutamol, fenoterol, and sodium cromoglycate on the release of heparin from sensitized human lung fragments challenged with Dermatophagoides pteronyssinus allergen. Am. J. Respir. Cell Mol. Biol. 1993, 8:518-521.
15. Halden Y., Rek A., Atzenhofer W., Szilak L., Wabnig A., Kungl A.J. Interleukin-8 binds to syndecan-2 on human endothelial cells. Biochem. J. 2004, 15:533-538.
16. Handel T.M., Johnson Z., Crown S.E., Lau E.K., Proudfoot A.E. Regulation of protein function by glycosaminoglycans - as exemplified by chemokines. Annu. Rev. Biochem. 2005, 74:385-410.
17. Hiebert L.M., Jacques L.B. The observation of heparin on endothelium after injection. Thromb. Res. 1976, 8:195-204.
18. Hoogewerf A.J., Kuschert G.S., Proudfoot A.E., Borlat F., Clark-Lewis I., Power C.A., Wells T.N. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry 1997, 36:13570-13578.
19. Humphries D.E., Wong G.W., Friend D.S., Gurish M.F., Qiu W.T., Huang C., Sharpe A.H., Stevens R.L. Heparin is essential for the storage of specific granule proteases in mast cells. Nature 1999, 400:769-772.
20. Johnson Z., Kosco-Vilbois M.H., Herren S., Cirillo R., Muzio V., Zaratin P., Carbonatto M., Mack M., Smailbegovic A., Rose M., Lever R., Page C., Wells T.N., Proudfoot A.E. Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine system. J. Immunol. 2004, 173:5776-5785.
21. Koenig A., Norgard-Sumnicht K., Linhardt R., Varki A. Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. J. Clin. Invest. 1998, 101:877-889.
22. Lever R., Page C.P. Novel drug development opportunities for heparin. Nat. Rev. Drug Discov. 2002, 1:140-148.
23. Lever R., Hoult J.R.S., Page C.P. The effects of heparin and related molecules upon the adhesion of polymorphonuclear leukocytes to vascular endothelium in vitro. Br. J. Pharmacol. 2000, 129:533-540.
24. Lever R., Lo W.T., Faraidoun M., Amin V., Brown R.A., Gallagher J., Page C.P. Size-fractionated heparins have differential effects on human neutrophil function in vitro. Br. J. Pharmacol. 2007, 151:837-843.
25. Ley K., Cerrito M., Arfors K.-E. Sulfated polysaccharides inhibit leukocyte rolling in rabbit mesentery venules. Am. J. Physiol. 1991, 260:H1667-H1673.
26. Ludwig R.J., Alban S., Boehncke W.H. Structural requirements of heparin and related molecules to exert a multitude of anti-inflammatory activities. Mini Rev. Med. Chem. 2006, 6:1009-1023.
27. Miller M.D., Krangel M.S. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit. Rev. Immunol. 1992, 12:17-46.
28. Nelson R.M., Cecconi O., Roberts W.G., Aruffo A., Linhardt R.J., Bevilacqua M.P. Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation. Blood 1993, 82:3253-3258.
29. Page C.P. One explanation of the asthma paradox: inhibition of natural anti-inflammatory mechanism by beta 2-agonists. Lancet 1991, 337:717-720.
30. Powell A.K., Yates E.A., Fernig D.G., Turnbull J.E. Interactions of heparin/heparan sulfate with proteins: appraisal of structural factors and experimental approaches. Glycobiology 2004, 14:17R-30R.
31. Salas A., Sans M., Soriano A., Reverter J.C., Anderson D.C., Pique J.M., Panes J. Heparin attenuates TNF-alpha induced inflammatory response through a CD11b dependent mechanism. Gut 2000, 47:88-96.
32. Sasaki M., Herd C.M., Page C.P. Effect of heparin and a low-molecular weight heparinoid on PAF-induced airway responses in neonatally immunized rabbits. Br. J. Pharmacol. 1993, 110:107-112.
33. Seeds E.A.M., Page C.P. Heparin inhibits allergen-induced eosinophil infiltration into guinea-pig lung via a mechanism unrelated to its anticoagulant activity. Pulm. Pharmacol. Ther. 2001, 14:111-119.
34. Seeds E.A.M., Horne A.P., Tyrrell D.J., Page C.P. The effect of inhaled heparin and related glycosaminoglycans on allergen-induced eosinophil infiltration in guinea-pigs. Pulm. Pharmacol. 1995, 8:97-105.
35. Silvestro L., Viano I., Macario M., Colangelo D., Montrucchio G., Panico S., Fantozzi R. Effects of heparin and its desulfated derivatives on leukocyte-endothelial adhesion. Semin. Thromb. Hemost. 1994, 20:254-258.
36. Skinner M.P., Lucas C.M., Burns G.F., Chesterman C.N., Berndt M.C. GMP-140 binding to neutrophils is inhibited by sulfated glycans. J. Biol. Chem. 1991, 266:5371-5374.
37. Smailbegovic A., Lever R., Page C.P. The effects of heparin on the adhesion of human peripheral blood mononuclear cells to human stimulated umbilical vein endothelial cells. Br. J. Pharmacol. 2001, 134:827-836.
38. Stevenson J.L., Choi S.H., Varki A. Differential metastasis inhibition by clinically relevant levels of heparins - correlation with selectin inhibition, not antithrombotic activity. Clin. Cancer. Res. 2005, 11:7003-7011.
39. Stevenson J.L., Varki A., Borsig L. Heparin attenuates metastasis mainly due to inhibition of P- and L-selectin, but non-anticoagulant heparins can have additional effects. Thromb. Res. 2007, 120:S107-S111.
40. Tangelder G.J., Arfors K.-E. Inhibition of leukocyte rolling in venules by protamine and sulfated polysaccharides. Blood 1991, 7:1565-1571.
41. Teixeira M.M., Hellewell P.G. Suppression by intradermal administration of heparin of eosinophil accumulation but not oedema formation in inflammatory reactions in guinea-pig skin. Br. J. Pharmacol. 1993, 110:1496-1500.
42. Vancheri C., Mastruzzo C., Armato F., Tomaselli V., Magri S., Pistorio M.P., LaMicela M., D'amico L., Crimi N. Intranasal heparin reduces eosinophil recruitment after nasal allergen challenge in patients with allergic rhinitis. J. Allergy Clin. Immunol. 2001, 108:703-708.
43. Wan M.X., Zhang X.W., Torkvist L., Thorlacius H. Low molecular weight heparin inhibits tumor necrosis factor alpha-induced leukocyte rolling. Inflamm. Res. 2001, 50:581-584.
44. Wang L., Brown J.R., Varki A., Esko J.D. Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins. J. Clin. Invest. 2002, 110:127-136.
45. Watt S.M., Williamson J., Genevier H., Fawcett J., Simmons D.L., Hatzfeld A., Nesbitt S.A., Coombe D.R. The heparin binding PECAM-1 adhesion molecule is expressed by CD34+ hematopoietic precursor cells with early myeloid and B-lymphoid cell phenotypes. Blood 1993, 82:2649-2663.
46. Xie X., Thorlacius H., Raud J., Hedqvist P., Lindbom L. Inhibitory effect of locally administered heparin on leukocyte rolling and chemoattractant-induced firm adhesion in rat mesenteric venules in vivo. Br. J. Pharmacol. 1997, 122:906-910.
47. Yanaka K., Nose T., Hindman B.J. Heparin ameliorates brain injury by inhibiting leukocyte accumulation. Stroke 1996, 27:2146-2147.